H 1150 Massachusetts House · 193rd Legislature (2023-2024)

An Act to ensure access to generic medication

This bill amends Massachusetts law to regulate how pharmacy benefit managers and insurance companies set reimbursement limits for generic drugs. It requires that any drug placed on a cost list must be proven to have multiple generic alternatives available and must remain on that list only as long as it meets these availability standards. The legislation also mandates that these cost lists be updated frequently and made available to pharmacies, while giving pharmacies a formal process to appeal if the set reimbursement amount is too low to cover their actual acquisition costs.
Bill status passed 3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Feb 2023
Senate Passage
Feb 2023
Governor
Introduced Feb 16, 2023 Last action May 30, 2024
Floor votes

How they voted

This bill passed the Senate. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
5
Key actions
1
Committee
1
Feb 16, 2023
Upper · Passed
Senate concurred
upper
Feb 16, 2023
Committee
Referred to the committee on Financial Services
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Alan Silvia
Alan Silvia
DDemocratic
MA
7th Bristol